bcl-2 Expression in pleural and extrapleural solitary fibrous tumours

Journal of Pathology

Volumn 181, Issue 4, 1997, Pages 362-367

  Chilosi, Marco ^a   Facchetti, Fabio ^b   Dei Tos, Angelo P ^c   Lestani, Maurizio ^a   Morassi, Maria L ^b   Martignoni, Guido ^a   Sorio, Claudio ^a   Benedetti, Alice ^a   Morelli, Luca ^a   Doglioni, Claudio ^d   Barberis, Massimo ^e   Menestrina, Fabio ^a   Viale, Giuseppe ^f  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Treviso Hospital   (Italy)

^d Hospital of Belluno   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

bcl 2; CD34; mesothelioma; solitary fibrous tumour

Indexed keywords

CD34 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMA; GASTROINTESTINAL TUMOR; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MALIGNANT MESOTHELIOMA; NEURILEMOMA; PLEURA TUMOR; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA; SYNOVIAL SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, FIBROUS TISSUE; PLEURAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030918126     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199704)181:4<362::AID-PATH764>3.0.CO;2-Y     Document Type: Article

References (36)

1. Yousem SA, Flynn SD. Intrapulmonary localized fibrous tumor. Intraparenchymal so-called localized fibrous mesothelioma. Am J Clin Pathol 1988; 89: 365-369.
2. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13: 640-658.
3. Young RH, Clement PB, McCaughey WTE. Solitary fibrous tumors (fibrous mesotheliomas) of the peritoneum: a report of three cases and a review of the literature. Arch Pathol Lab Med 1990; 114: 493-495.
4. Witkin GB, Rosai J. Solitary fibrous tumor of the upper respiratory tract: a report of six cases. Am J Surg Pathol 1991; 15: 842-848.
5. Goodlad JR, Fletcher CDM. Solitary fibrous tumour arising at unusual sites: an analysis of a series. Histopathology 1991; 19: 515-522.
6. Cameselle-Teijeiro J, Varela-Duran J, Fonseca E, Villanueva JP, Sobrinho-Simoes M. Solitary fibrous tumor of the thyroid. Am J Clin Pathol 1994; 101: 535-538.
7. Bost F, Barnoud R, Peoc'h M. Le Marc'hadour F, Pasquier D, Pasquier B. CD34 positively in solitary fibrous tumor of the liver. Am J Surg Pathol 1995; 19: 1334-1335.
8. van-de-Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994; 18: 814-820.
9. Suster S, Nascimento AG, Miettinen M, Sickel JZ, Moran CA. Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol 1995; 19: 1257-1266.
10. Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol 1994; 18: 992-998.
11. Moran CA, Suster S, Koss MN. The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura. Semin Diagn Pathol 1992; 9: 169-180.
12. Crotty TB, Myers JL, Katzenstein ALA, Tazelaar HD, Swensen SJ, Churg A. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol 1994; 18: 357-363.
13. Moran CA, Suster S, Koss MN. Smooth muscle tumours presenting as pleural neoplasms. Histopathology 1995; 27: 227-234.
14. Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995; 26: 440-449.
15. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle shaped cells in Kaposi's sarcoma. Arch Dermatol 1991; 127: 523-529.
16. van de Rijin M, Rouse RV. CD34: a review. Appl Immunohistochem 1994; 2: 71-80.
17. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol 1995; 26: 428-431.
18. Renshaw AA, Pinkus GS, Corson JM. CD34 and AE1/AE3. Diagnostic discriminants in the distinction of solitary fibrous tumor of the pleura from sarcomatoid mesothelioma. Appl Immunohistochem 1994; 2: 94-102.
19. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
20. Viale G, Roncalli M, Grimelius L, et al. Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 1995; 26: 945-950.
21. Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20: 1037-1046.
22. Gershoni JM. Palade GE. Protein blotting: principles and applications. Anal Biochem 1983; 131: 1-15.
23. Laemmli UK. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
24. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990; 137: 225-232.
25. Segers K, Ramael M, Singh SK, et al. Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium. Virchows Arch 1994; 424: 631-634.
26. Finke J, Fritzen R, Ternes P, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992; 80: 459-469.
27. Baer R. bcl-2 breathes life into embryogenesis. Am J Pathol 1994; 145: 7-10.
28. Lu Q-L, Abel P, Foster CS, Lalani E-N. bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996; 27: 102-110.
29. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993; 329: 690-694.
30. Joensuu H, Pylkkanen L, Toikkanen S. bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994; 145: 1191-1198.
31. Mikhael AI, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 1994; 2: 89-93.
32. Miettinen M, Virolainen M, Rikala MS. Gastrointestinal stromal tumors. Value of CD34 antigen in their identification and separation from true leiomyomas and Schwannomas. Am J Surg Pathol 1995; 19: 207-216.
33. Ueyama T, Guo K-J, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992; 69: 947-955.
34. Gibbs AR. Smooth muscle tumours of the pleura. Histopathology 1995; 27: 295-296.
35. Newman PL, Wadden C, Fletcher CDM. Gastrointestinal stromal tumors: correlation of immunophenotype with clinicopathological features. J Pathol 1991; 164: 107-117.
36. Fletcher CDM. Benign fibrous histiocytoma of subcutaneous and deep soft tissue: a clinicopathologic analysis of 21 cases. Am J Surg Pathol 1990; 14: 801-809.